Exenatide improves postprandial hyperglycemia and dyslipidemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, Mathijs C.
Corner, Anja
Diamant, Michaela
Eliasson, Bjorn
Malloy, Jaret L.
Shaginian, Rimma M.
Ding, Wei
Kendall, David M.
Smith, Ulf
Yki-Jarvinen, Hannele
Heine, Robert J.
Taskinen, Marja-Ritta
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [1] Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes
    Bunck, M. C.
    Corner, A.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    Taskinen, M. R.
    DIABETOLOGIA, 2008, 51 : S351 - S351
  • [2] Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
    Cervera, Antonio
    Wajcberg, Estela
    Sriwijitkamol, Apiradee
    Fernandez, Marianella
    Zuo, Pengou
    Triplitt, Curtis
    Musi, Nicolas
    DeFronzo, Ralph A.
    Cersosimo, Eugenio
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05): : E846 - E852
  • [3] Mathematical modeling shows exenatide improved postprandial β-cell function in patients with type 2 diabetes treated with merformin or metformin and sulfonylurea
    Mari, A
    Halseth, A
    Nanayakkara, N
    Nielsen, L
    Defronzo, R
    Ferrannini, E
    DIABETES, 2005, 54 : A119 - A119
  • [4] One year treatment with exenatide improves β cell function and glycaemic control in metformin treated type 2 diabetes patients
    Bunck, M. C.
    Diamant, M.
    Corner, A.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M.-R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    DIABETOLOGIA, 2007, 50 : S111 - S112
  • [5] PREDICTORS OF POSTPRANDIAL HYPERGLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Nita, C. A.
    Rusu, A.
    Bala, C. G.
    Hancu, N.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2009, 5 (02) : 177 - 182
  • [6] One Year Exenatide Therapy, Compared with Insulin Glargine, Reduces Postprandial Oxidative Stress in Metformin-Treated Patients with Type 2 Diabetes
    Bunck, Mathijs C.
    Corner, Anja
    Eliasson, Bjorn
    Wu, Yan
    Shaginian, Rimma M.
    Yan, Ping
    Heine, Robert J.
    Smith, Ulf
    Yki-Jaervinen, Hannele
    Taskinen, Marja-Riitta
    Diamant, Michaela
    DIABETES, 2009, 58 : A147 - A147
  • [7] Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes
    Feinglos, MN
    Thacker, CH
    English, J
    Bethel, MA
    Lane, JD
    DIABETES CARE, 1997, 20 (10) : 1539 - 1542
  • [8] Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
    Toru Hiyoshi
    Mutsunori Fujiwara
    Zemin Yao
    TheJournalofBiomedicalResearch, 2019, 33 (01) : 1 - 16
  • [9] Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
    Hiyoshi, Toru
    Fujiwara, Mutsunori
    Yao, Zemin
    JOURNAL OF BIOMEDICAL RESEARCH, 2019, 33 (01): : 1 - 16
  • [10] EXENATIDE VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES INADEQUATELY TREATED WITH METFORMIN
    Polyzos, S. A.
    Zografou, I.
    Karagianni, P.
    Kartali, N. I. K. I.
    Sampanis, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A50 - A50
12345